We work closely with MedTech teams to translate early innovation into viable, investable, and regulatory-ready products. Whether you're validating a concept, preparing for a capital raise, or building a quality system from the ground up, we provide practical, risk-informed guidance to move your innovation forward with clarity and confidence.
Have a question or want to discuss your project with us? We're here to help. Fill out the form below and we'll be in touch as soon as possible.
Solentropy provides independent due diligence for investors and works closely with startups and research teams to shape and execute capital raise strategies. We've successfully led a Class III, TRL 2 medical device through product development and onto the market, raising over USD $20 million along the way. We work with founders to identify value inflection points, reduce technical and regulatory risk, and build investor confidence through structured, stage-appropriate planning.
We work with MedTech teams across all stages of development to ensure product strategy is grounded in real-world needs, market context, and regulatory expectations. We support early scoping and validation through to formal requirements development, helping you define what to build, for whom, and why. Our process bridges market understanding with technical execution.
We help teams design a clear and structured product development roadmap. From Proof-of-Principle to Proof-of-Concept, and into Alpha and Beta prototyping, we support every stage of development with practical, risk-informed guidance.
Our approach is grounded in globally recognised PMBOK project management principles. We focus on turning identified risks into technical requirements, verification strategies, and manufacturing plans. Our team has worked with many of Australia’s leading development and manufacturing firms and can support both internal teams and external partners.
We work with startups to design and implement fit-for-purpose Quality Management Systems that meet the requirements of ISO 13485 and other relevant standards. We help ensure you are well-prepared for both internal and external audits, and aligned with regulatory expectations from the outset.
We do not provide legal advice, but we work alongside your IP counsel to help make sense of the patent landscape and shape a strategy that supports product development and commercial goals. Our role is to identify relevant patents, reduce freedom to operate risk, and support the creation of strong, investor-attractive foreground IP. In one project, we narrowed a dataset of over 142,000 patents down to 88 that required technical evaluation. All were eliminated without needing legal support, and our work contributed to the development and global granting of new foreground patents, significantly strengthening the company’s valuation.
We provide support to navigate Class I to Class III regulatory requirements by helping define a clear and achievable regulatory pathway. While we do not provide legal or notified body advice, we ensure your development activities align with relevant standards and compliance expectations. Our work focuses on integrating regulatory needs into your product planning from the outset, ensuring traceability across risk, requirements, and verification activities.
We help MedTech teams engage with clinicians early and effectively, ensuring product development is grounded in clinical relevance and real-world use. We support alignment with clinical needs, decision-making environments, and healthcare delivery contexts to improve adoption potential and usability.
Understanding how your product will be paid for is critical to long-term success. We help teams assess reimbursement opportunities, frame their health economic value, and plan evidence generation that supports adoption and funding.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.